Human Imatinib Mesylate-Resistant Leukaemia Cell Line

The human ALL cell line, named BV173, was altered to be imatinib resistant and contains the most frequently observed mutation (E255K) responsible for drug resistance in patients.

Contributors

Inventor Institute
Steven Grant Virginia Commonwealth University
SKU: 154032
Product description: The human ALL cell line, named BV173, was altered to be imatinib resistant and contains the most frequently observed mutation (E255K) responsible for drug resistance in patients.
Parental cell line: BV173
Disease: Cancer
Cat. #: 154032
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Cancer types: Blood cancer
Research Fields: Cancer
Organism: Human
Cancer Types In Detail: Acute Lymphoblastic Leukemia (Ph+ ALL);Chronic Myelogenous Leukemia (CML)
Format: Frozen
Shipping conditions: Dry ice
References:

Cormack et al. 1992. J Mol Biol. 228(4):1078-90. PMID: 1474579.

Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.